HIGHLIGHTS
- who: Rhinocerebral Mucormycosis (RCM and collaborators from the College and Hospital, Chitradurga, Chitradurga, Karnataka, India have published the research: INTERNATIONAL JOURNAL OF PRECLINICAL AND CLINICAL RESEARCH, in the Journal: (JOURNAL)
- what: In a parallel study that the authors conducted that is yet to be published, wherein the authors compare this data with control group of patients with COVID, it was found that despite the same treatment, they did not develop mucormycosis.
- how: This result is in concordance with other studies .
- future: It was also observed that majority of Mucormycosis patients had . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.